Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dr Ham's test revisited.

Literature DB >> 1859875

Dr Ham's test revisited.

W F Rosse.

Abstract

Mesh：

Substances：
Antigens, CD

Year: 1991 PMID： 1859875

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. DIAGNOSTIC DILEMMAS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

Authors: Rajat Kumar; S Dutta; Harsh Kumar; A I Lazar; V K Sashindran
Journal: Med J Armed Forces India Date: 2017-06-27

2. Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.

Authors: Régis Peffault de Latour; Hubert Schrezenmeier; Andrea Bacigalupo; Didier Blaise; Carmino A de Souza; Stephane Vigouroux; Roelf Willemze; Louis Terriou; Andre Tichelli; Mohamad Mohty; Sophie de Guibert; Judith C Marsh; Jakob Passweg; Jean Yves Mary; Gerard Socié
Journal: Haematologica Date: 2012-06-11 Impact factor: 9.941

3. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.

Authors: M Hatanaka; T Seya; M Matsumoto; T Hara; M Nonaka; N Inoue; J Takeda; A Shimizu
Journal: Biochem J Date: 1996-03-15 Impact factor: 3.857

7. Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria.

Authors: M Takahashi; J Takeda; S Hirose; R Hyman; N Inoue; T Miyata; E Ueda; T Kitani; M E Medof; T Kinoshita
Journal: J Exp Med Date: 1993-02-01 Impact factor: 14.307

7 in total

Dr Ham's test revisited.

1. DIAGNOSTIC DILEMMAS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

2. Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.

3. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.

4. Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.

5. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab.

6. Hepatic manifestations in hematological disorders.

7. Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria.